Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 5.
doi: 10.1007/s00261-025-04998-6. Online ahead of print.

10 mm (PI-RADS v2.1) versus 15 mm (PI-RADS v1.0) tumor capsule contact length in predicting extracapsular extension in prostate cancer: Meta-analysis and systematic review

Dheeman Futela  1 , Mahima Bhargava  2 , Sharath Rama  3 , Sishir Doddi  4 , Yong Chen  5 , Nikhil H Ramaiya  5 , Sree Harsha Tirumani  6
Affiliations

10 mm (PI-RADS v2.1) versus 15 mm (PI-RADS v1.0) tumor capsule contact length in predicting extracapsular extension in prostate cancer: Meta-analysis and systematic review

Dheeman Futela et al. Abdom Radiol (NY). .

Abstract

Objective: To determine the diagnostic performance of tumor capsule contact length (TCCL) and to determine its optimal cut-off on prostate MRI to predict extra-capsular extension (ECE) at histopathology of radical prostatectomy specimen in patients with prostate cancer.

Materials and methods: An electronic search of the PUBMED and EMBASE databases was performed until December 31, 2024 to identify studies analyzing TCCL as a predictor of ECE on prostate MRI. Pooled sensitivity and specificity of all studies were plotted in a hierarchical summary receiver operating characteristic plot and the risk of ECE was evaluated using bivariate random-effects meta-analysis. Meta-regression analysis for various TCCL cut-offs was performed.

Results: Twenty-three eligible studies were found. Reported sensitivity (between 47 - 94%) and specificity (between 46 - 88%) showed significant heterogeneity between studies, without evident threshold effect. Pooled sensitivity and specificity of TCCL for predicting ECE was 76.3% and 68.8% respectively with AUC of 0.787 for the summary ROC curve. Meta-regression analysis showed no significant difference in diagnostic performance according to various TCCL cutoffs, measurement methods, or ISUP grade distribution. Studies with 14 mm threshold had similar sensitivity (73%), but greater specificity (74% vs. 70%) and diagnostic odds ratio (8.3 vs. 6.5), when compared to 10 mm threshold.

Conclusion: TCCL on MRI has reasonable pooled sensitivity and specificity to predict ECE. While sensitivity remained moderately high for all TCCL thresholds, specificity at 14 mm (cutoff close to 15 mm suggested by PI-RADS v1.0) threshold was greater than that at 10 mm (cutoff suggested by PIRADS v2.1). This cutoff can be helpful in developing objective likelihood scores for ECE prediction on MRI.

Keywords: Extraprostatic extension; Magnetic resonance imaging; Meta-analysis; Prostate cancer.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Similar articles

See all similar articles

References

    1. Litwin MS, Tan HJ. The Diagnosis and Treatment of Prostate Cancer: A Review. JAMA. 2017;317:2532–2542. - DOI - PubMed
    1. Carroll PH, Mohler JL. NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection. J Natl Compr Canc Netw. 2018;16:620–623. - DOI - PubMed
    1. Kozikowski M, Malewski W, Michalak W, Dobruch J. Clinical utility of MRI in the decision-making process before radical prostatectomy: Systematic review and meta-analysis. PLoS One. 2019;14:e0210194. - DOI - PubMed - PMC
    1. Mehralivand S, Shih JH, S RB. A Magnetic Resonance Imaging-Based Prediction Model for Prostate Biopsy Risk Stratification. JAMA Oncol. 2018;4:678–685. - DOI - PubMed - PMC
    1. Padhani AR, Weinreb J, Rosenkrantz AB, Villeirs G, Turkbey B, Barentsz J. Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions. Eur Urol. 2019;75:385–396. - DOI - PubMed

LinkOut - more resources